Demand for Anti-VEGF Injections for Retinal Diseases Expected to Surge

(MedPage Today) -- The demand for intravitreal vascular endothelial growth factor (VEGF) inhibitor therapy is forecasted to increase by about 50% over the next 5 years in Denmark, due largely to an aging population, a nationwide cohort study showed...
Source: MedPage Today Primary Care - Category: Primary Care Source Type: news